Windtree Therapeutics Launches $200M BNB Treasury Strategy
Windtree Therapeutics, a NASDAQ-listed biotech firm, has launched a $200M securities purchase agreement with Build & Build Corporation to implement a BNB treasury strategy. The deal allows Windtree to raise an additional $140M, funded by cash, Osprey BNB Chain Trust shares and BNB tokens. Shares jumped 14.44% pre-market following the announcement. As the first NASDAQ company to offer direct Binance Coin exposure, Windtree targets institutional investors and retail traders. BNB treasury strategy leverages daily trading volumes above $2B to optimize liquidity and diversify asset portfolios. Executives Jed Latkin and Patrick Horsman describe this innovative crypto treasury management approach. At publication, BNB trades at $717, up 9% over 14 days but still 8.6% below its all-time high.
Bullish
Windtree’s BNB treasury strategy is likely bullish for BNB. Short-term, the stock’s 14.44% pre-market surge and planned purchase of BNB tokens indicate increased demand, supporting upward price pressure. Long-term, Windtree’s institutional adoption and expanded token exposure signal growing confidence in BNB as a treasury asset, potentially driving further capital inflows and greater market stability.